KPWS
AQST icon

Kestra Private Wealth Services’s Aquestive Therapeutics AQST Stock Holding History

Kestra Private Wealth Services’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Hold
10,750
– – ﹤0.01% 1773
2026
Q1 		$44.6K Hold
10,750
– – ﹤0.01% 1714
2025
Q4 		$69.4K Hold
10,750
– – ﹤0.01% 1675
2025
Q3 		$60.1K Buy
+10,750
New +$46.5K ﹤0.01% 1628
2023
Q3 		– Sell
-16,732
Closed -$27.6K – 1170
2023
Q2 		$27.6K Buy
+16,732
New +$30.3K ﹤0.01% 1063

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SWRP
Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Kestra Private Wealth Services's AQST Position: Q2 2026 in Review

Kestra Private Wealth Services held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 10,750 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Kestra Private Wealth Services first reported a position in AQST in Q2 2023 and has held it in 5 quarters since. The position peaked at $69.4K in Q4 2025. 29 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Kestra Private Wealth Services held 10,750 shares of Aquestive Therapeutics worth $44.7K as of Q2 2026.
  • Kestra Private Wealth Services left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1773 holding.
  • Kestra Private Wealth Services first reported a position in Aquestive Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • Kestra Private Wealth Services's Aquestive Therapeutics position peaked at $69.4K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.